Outcomes of Drug Resistant Epileptic Pediatric Patient by Modified Atkins Diet
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- This is an observational study: the protocol does not assign a study treatment.
- Who it may be relevant to
- Registry conditions: Drug Resistant Epilepsy. Basic parameters: 1 year — 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Egypt
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Overview
To assess clinical outcomes in drug resistant epileptic pediatric patient by modified atkin diet with focusing on following points: 1. Control of seizures(frequency , duration and numbers of hospital admissions) . 2. Quality of life by pediatric quality of life inventory v4. 3. Cognitive function by stanford binet intelligence scale 5th edition. 4. Growth parameters ( weight, height will be combined to report BMI in kg/m\^2).
Primary outcome measures
- 1-Control of seizures(frequency and duration of seizures) . 2-Quality of life by pediatric quality of life inventory v4. 3-Cognitive function by stanford binet intelligence scale 5th edition. 4-Growth parameters (weight and height by BMI in kg/m^2) [Time frame: 6 month]
Secondary outcome measures (1)
- to detect clinical predictors of seizures control ( frequency of attack and duration) in patients with drug resistant epilepsy using MAD. [Time frame: 6 month]
Eligibility criteria
Inclusion criteria
- Children aged 1-18 years.
- Diagnosed with drug-resistant epilepsy according to ILAE definition.\[2\]
- On KD for at least 6 months.
Exclusion criteria
- \- Patients with contraindicated metabolic/genetic conditions.
- Non-compliance with KD .
Patients on alternative dietary therapies (e.g., low glycemic diet)
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Study design
- Observational model
- Case-only
Study locations
Egypt · 1 center
- Sohag faculty of medicine — Sohag
Identifiers
NCT: NCT07275125 · Soh-med-25-9-IMS